| Financial Year |
March 31 2023 |
| Monetary Funds |
6,032,253,600.27 |
| Held-for-trading Financial Assets |
440,745,186.59 |
| Notes Receivable |
90,913,547.16 |
| Accounts Receivable |
829,589,718.40 |
| Advances to Suppliers |
253,987,681.17 |
| Other Receivables |
48,573,705.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
353,376,715.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
80,786,540.31 |
| Total Current Assets |
8,227,511,469.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
553,830,895.76 |
| Investment Properties |
1,207,513.26 |
| Fixed Assetes |
2,190,863,482.40 |
| Under-construction Projects |
845,489,028.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
278,533,286.43 |
| R&D expenses |
-- |
| Goodwill |
922,450,800.07 |
| Long-Term Deferred and Prepaid Expenses |
3,259,816.69 |
| Deferred Income Tax Assets |
26,139,124.71 |
| Other Non-Current Assets |
229,581,264.79 |
| Sub-Total of Non-Current Assets |
5,146,863,688.66 |
| Total Assets |
13,374,375,158.62 |
| Short-Term Loans |
1,065,435,938.54 |
| Trading Financial liabilities |
140,092,282.66 |
| Notes Payable |
-- |
| Accounts Payable |
837,856,965.02 |
| Accounts Received In Advance |
1,921,500.00 |
| Employee Compensation Payable |
32,898,857.54 |
| Taxes Payable |
131,903,436.47 |
| Interest Payable |
2,500,000.00 |
| Dividend Payable |
-- |
| Other payables |
199,079,301.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
136,387,216.01 |
| Other Current Liabilities |
18,074,635.23 |
| Sub-Total of Current Liabilities |
2,751,680,418.53 |
| Long-term Loans |
582,000,000.00 |
| Bonds Payable |
1,988,313,193.69 |
| Long-Term Accounts Payable |
314,849,980.64 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
39,052,749.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,012,085,991.90 |
| Total Liabilities |
5,763,766,410.43 |
| Paid-In Capital(Or Share Stock) |
625,414,024.00 |
| Capital Surplus |
3,180,317,729.06 |
| Surplus Reserve |
57,983,674.71 |
| LESS:Treasury Stock |
150,034,761.55 |
| Undistributed Profits |
3,376,000,410.57 |
| Minority Stockholder's Interest |
239,569,128.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,371,039,620.05 |
| Owner's Equity（Stockholder's Equity） |
7,610,608,748.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,374,375,158.62 |
